Altogether, we identified one of the key mechanisms of T cell-mediated immunopathology in Covid19 by showing that Foxo1 and IL-9 controls two distinctive pathological features that critically contribute to the progression and severity of COVID-19—namely anti-viral pathway and airway inflammation. Here, FOXO1 is linked to COVID-19.